Related Experiment Video
Updated: Sep 23, 2026

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Intravesical Bacillus Calmette-Guerin for treating bladder cancer
1Southwest Florida Urologic Associates, Cape Coral, FL, USA.
Urologic Nursing
|July 17, 2003
Abstract:
Bladder cancer continues to be a leading cause of malignant neoplasm in men. Since 1976, Bacillus Calmette-Guerin (BCG) has been a recommended treatment for superficial bladder malignancy. BCG treatment indications, administration, side effects, patient education, and nursing implications are discussed.
